Showing results (101-110 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|March 29, 2026
Time to pregnancy in women with rheumatoid arthritis who want to conceive treated according to a treat-to-target approach: a comparison of an observational cohort with a historical reference cohortCornelia H Quaak, Esther Röder, Hetty M Wintjes, et al.
The Lancet. Rheumatology|May 4, 2026
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled studyMikkel Østergaard, Espen A Haavardsholm, Miroslawa Nowak, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
The Lancet. Rheumatology|May 9, 2026
Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional studyKeno Bressem, Murat Torgutalp, Torsten Diekhoff, et al.
The Lancet. Rheumatology|July 2, 2026
Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trialElise van Mulligen, Quirine A Dumoulin, Hanna W van Steenbergen, et al.
The Lancet. Rheumatology|June 29, 2026
Secukinumab biosimilar BAT2306 versus reference secukinumab in patients with moderate-to-severe plaque psoriasis: a multicentre, double-blind, randomised, active-controlled, phase 3 trialJia-Qi Chen, Rongyi Chen, Liming Wu, et al.
The Lancet. Rheumatology|August 14, 2026
Defining age-related thresholds in hand, wrist, and foot ultrasound: an international, cross-sectional, observational study by the Outcome Measures in Rheumatology Ultrasound Working GroupIlfita Sahbudin, Jeanette Trickey, Hélène Gouze, et al.
The Lancet. Rheumatology|August 3, 2026
Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trialsKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
The Lancet. Rheumatology|August 17, 2026
Addressing the urgent need for clinical trials in chronic non-bacterial osteomyelitisChristian M Hedrich, Eve Roberts, Giulia Inguscio, et al.
The Lancet. Rheumatology|September 16, 2026
Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trialAndreas Goebel, Paul Meisner, Gustaf Rydevik, et al.
Pageof 47